Oliver Luxxe Assets LLC

Position in INVA — Innoviva, Inc.

CIK 1666239 GLADSTONE, NJ

Position in INVA

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,338,913

-$640,655 QoQ

Shares Held

58,957

-30.6% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

of 18 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

Oliver Luxxe Assets LLC holds $10,072,172 across 5 Biotechnology names. INVA ranks #4 (13.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	18,860	$4,544,694
2	HALO	Halozyme Therapeutics, Inc.	33,014	$2,584,005
3	CPRX	Catalyst Pharmaceuticals, Inc.	49,744	$1,563,453
4	INVA	Innoviva, Inc. This page	58,957	$1,338,913
5	GANX	Gain Therapeutics, Inc.	20,250	$41,107

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,338,913	58,957	-30.6%	Shares	Sole	2026-07-09
2026-03-31	$1,979,568	84,960	+0.3%	Shares	Sole	2026-04-08
2025-12-31	$1,692,573	84,671	—	Shares	Sole	2026-01-08
No filing history on record for this holder in this stock.